Your browser doesn't support javascript.
loading
Underreporting of Major Cardiac Adverse Events With Immune Checkpoint Inhibitors in Clinical Trials: Importance of Postmarketing Pharmacovigilance Surveys.
Palassin, Pascale; Faillie, Jean-Luc; Coustal, Cyrille; Quantin, Xavier; Topart, Delphine; Roubille, François; Maria, Alexandre T J.
Afiliação
  • Palassin P; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
  • Faillie JL; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
  • Coustal C; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
  • Quantin X; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
  • Topart D; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
  • Roubille F; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
  • Maria ATJ; Pascale Palassin, PharmD, PhD, and Jean-Luc Faillie, MD, PhD, Regional Pharmacovigilance Centre, Department of Medical Pharmacology and Toxicology, Montpellier University Hospital, Montpellier, France; Cyrille Coustal, MD, Department of Internal Medicine-Multi-Organic Diseases, Local Referral Center
J Clin Oncol ; 41(5): 1154-1156, 2023 02 10.
Article em En | MEDLINE | ID: mdl-36318740
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Antineoplásicos Imunológicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article